|
Size: 10048
Comment:
|
Size: 10040
Comment:
|
| Deletions are marked like this. | Additions are marked like this. |
| Line 4: | Line 4: |
| ||<style="text-align:center;">{{attachment:UofManitoba.png||width=150}}||[[ http://umanitoba.ca/ |University of Manitoba]]||Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes <<BR>><<BR>>Pl: Kevin Coombs||2020-2021|| | ||<style="text-align:center;">{{attachment:CIHR.jpg||width=150}}||[[ http://umanitoba.ca/ |University of Manitoba]]||Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes <<BR>><<BR>>Pl: Kevin Coombs||2020-2021|| |
| Line 7: | Line 7: |
| ||<style="text-align:center;">{{attachment:cfref.png||width=150}}||[[ https://www.cfref-apogee.gc.ca/home-accueil-eng.aspx |Canada First Research Excellence Fund]]||Stem cell based approaches to endogenous repair of brain and skeletal muscle <<BR>><<BR>> sPON rEF:MBDC2-2019-02 <<BR>><<BR>>PI's: Freda Miller, Alison McGuigan, Peter Zandstra, Penny Gilbert, Sidhartha Goyal, Cindi Morshead, Yun Li, David Kaplan ||2019-2020|| | ||<style="text-align:center;">{{attachment:cfref.png||width=150}}||[[ https://www.cfref-apogee.gc.ca/home-accueil-eng.aspx |Canada First Research Excellence Fund]]||Stem cell based approaches to endogenous repair of brain and skeletal muscle <<BR>><<BR>> Spon Ref::MBDC2-2019-02 <<BR>><<BR>>PI's: Freda Miller, Alison McGuigan, Peter Zandstra, Penny Gilbert, Sidhartha Goyal, Cindi Morshead, Yun Li, David Kaplan ||2019-2020|| |
| Line 12: | Line 12: |
| ||<style="text-align:center;">{{attachment:OICR.jpeg||width=150}}||[[ https://oicr.on.ca/ |Ontario Institute for Cancer Research]]||The Cancer Genome Collaboratory <<BR>><<BR>>Pl: Lincoln Stein <<BR>><<BR>>The authors wish to acknowledge the funding support of the Canada Foundation for Innovation Cyberinfrastructure Initiative, the Ontario Research Fund, BC Knowledge Development Fund and the Ministère de l'Économie, de la Science et l'Innovation for 'The Cancer Genome Collaboratory' project||2016-2022|| | ||<style="text-align:center;">{{attachment:CFI.png||width=200}}||[[ https://oicr.on.ca/ |Ontario Institute for Cancer Research]]||The Cancer Genome Collaboratory <<BR>><<BR>>Pl: Lincoln Stein <<BR>><<BR>>The authors wish to acknowledge the funding support of the Canada Foundation for Innovation Cyberinfrastructure Initiative, the Ontario Research Fund, BC Knowledge Development Fund and the Ministère de l'Économie, de la Science et l'Innovation for 'The Cancer Genome Collaboratory' project||2016-2022|| |
Funding Agency |
Title |
Grant Period |
|
|
Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes |
2020-2021 |
|
|
AI for Precision Discovery on Associations in Biological Systems |
2020-2021 |
|
|
A reference cell atlas of human liver diversity of a lifespan |
2019-2021 |
|
|
Stem cell based approaches to endogenous repair of brain and skeletal muscle |
2019-2020 |
|
|
Investigating how age-related clonal hematopoiesis drives HSC stemness properties ane how this leads to inflammatory disease of the heart |
2019-2020 |
|
|
Development of novel cell and tissue therapies to treat liver failure |
2019-2020 |
|
|
Cellular and Genetic Heterogeneity as a Therapeutic Hurdle and Opportunity for Ontarians with Brain Cancer (Operating Grant) |
2017-2021 |
|
|
Acute Leukemia Translational Initiative (Operating Grant) |
2017-2021 |
|
|
The Cancer Genome Collaboratory |
2016-2022 |
|
|
Cell and tissue communication networks |
2016-2021 |
|
|
Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). |
2016-2019 |
|
|
Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). |
2016-2019 |
|
|
Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). |
2016-2019 |
|
|
From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant) |
2015-2022 |
|
|
Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) |
2015-2020 |
|
|
A human binary interactome reference map by 2020 (Operational sub-grant:U41-HG001715-18). |
2015-2018 |
|
|
Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) |
2015-2019 |
|
|
The Cancer Genome Collaboratory (Operating Grant: Discovery Frontiers) |
2014-2018 |
|
|
Cancer stem cell program (Operating Grant) |
2013-2017 |
|
|
Personalised Risk Stratification for Prevention and Early Detection of Breast Cancer (Operating Sub-Grant) |
2013-2017 |
|
|
National Resource for Network Biology (NRNB), PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader. |
2012-2017 |
|
|
U.S. NIH via National Institute of General Medical Sciences (NIGMS) |
Cytoscape: A Modeling Platform for Biomolecular Networks |
2009-2017 |
|
U.S. NIH via National Human Genome Research Institute (NHGRI) |
Pathway Commons Research resource for biological pathways. |
2008-2018 |
|
A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324) |
2007-2017 |
|
|
Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research (Operating Sub-Grant: 69119295) |
2006-2017 |
|
